Dr. Bassem B. Maximos

League City, TX
Specialties:Obstetrics and Gynecology
Accepting New Patients
OverviewInsuranceLocationsClinical Research

Overview

Bassem Maximos is an Obstetrics and Gynecologist in League City, Texas. His top areas of expertise are Vaginal Yeast Infection, Ovarian Cysts, Vulvovaginitis, and Menorrhagia. Dr. Maximos is currently accepting new patients.

His clinical research consists of co-authoring 2 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Obstetrics and Gynecology
Licenses
Obstetrics & Gynecology in TX
Languages Spoken
English
Spanish
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Community Health
  •  Friday Health
  •  Humana

Locations

651 N Egret Bay Blvd, Suite H, League City, TX 77573
832-632-1333

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase III, Randomized, Double-blind, Placebo-controlled Multi-country Study to Demonstrate Efficacy of a Single Dose of Unadjuvanted RSV Maternal Vaccine, Administered IM to Pregnant Women 18 to 49 Years of Age, for Prevention of RSV Associated LRTIs in Their Infants up to 6 Months of Age
A Phase III, Randomized, Double-blind, Placebo-controlled Multi-country Study to Demonstrate Efficacy of a Single Dose of Unadjuvanted RSV Maternal Vaccine, Administered IM to Pregnant Women 18 to 49 Years of Age, for Prevention of RSV Associated LRTIs in Their Infants up to 6 Months of Age
Enrollment Status: Terminated
Publish Date: February 20, 2025
Intervention Type: Biological, Drug
Study Drug: RSV Maternal vaccine
Study Phase: Phase 3
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled, Clinical Study to Assess the Efficacy and Safety of Linzagolix in Subjects With Moderate to Severe Endometriosis-associated Pain.
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled, Clinical Study to Assess the Efficacy and Safety of Linzagolix in Subjects With Moderate to Severe Endometriosis-associated Pain.
Enrollment Status: Terminated
Publish Date: October 29, 2024
Intervention Type: Drug
Study Phase: Phase 3
A Phase III, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Safety, Reactogenicity and Immune Response of a Single Intramuscular Dose of Unadjuvanted RSV Maternal Vaccine, in High Risk Pregnant Women Aged 15 to 49 Years and Infants Born to the Vaccinated Mothers
A Phase III, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Safety, Reactogenicity and Immune Response of a Single Intramuscular Dose of Unadjuvanted RSV Maternal Vaccine, in High Risk Pregnant Women Aged 15 to 49 Years and Infants Born to the Vaccinated Mothers
Enrollment Status: Terminated
Publish Date: February 06, 2024
Intervention Type: Biological, Drug
Study Phase: Phase 3
AMPOWER A Single-arm, Phase III, Open Label, Multi-center, Study in Women Aged 18-35 Years of the Contraceptive Efficacy and Safety of Phexxi™ (Previously Referred to as AMPHORA®) Contraceptive Vaginal Gel
AMPOWER A Single-arm, Phase III, Open Label, Multi-center, Study in Women Aged 18-35 Years of the Contraceptive Efficacy and Safety of Phexxi™ (Previously Referred to as AMPHORA®) Contraceptive Vaginal Gel
Enrollment Status: Completed
Publish Date: September 17, 2020
Intervention Type: Drug
Study Phase: Phase 3
Phase 2B Double-blind Placebo-controlled Efficacy Trial of EVO100 (Previously Known as Amphora ® Gel) for the Prevention of Acquisition of Urogenital Chlamydia Trachomatis Infection
Phase 2B Double-blind Placebo-controlled Efficacy Trial of EVO100 (Previously Known as Amphora ® Gel) for the Prevention of Acquisition of Urogenital Chlamydia Trachomatis Infection
Enrollment Status: Completed
Publish Date: August 12, 2020
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
View 4 Less Clinical Trials

2 Total Publications

Phase 3 study evaluating the safety and efficacy of oteseconazole in the treatment of recurrent vulvovaginal candidiasis and acute vulvovaginal candidiasis infections.
Phase 3 study evaluating the safety and efficacy of oteseconazole in the treatment of recurrent vulvovaginal candidiasis and acute vulvovaginal candidiasis infections.
Journal: American journal of obstetrics and gynecology
Published: January 05, 2022
Similar Doctors
Expertise in
21
conditions
Dr. Shannon N. Westin
Obstetrics and Gynecology | Oncology
Expertise in
21
conditions
Dr. Shannon N. Westin
Obstetrics and Gynecology | Oncology

MD Anderson

7900 Fannin St, Suite 2500, 
Houston, TX 
 (22.3 mi)
713-792-1380
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Shannon Westin is an Obstetrics and Gynecologist and an Oncologist in Houston, Texas. Dr. Westin is highly rated in 21 conditions, according to our data. Her top areas of expertise are Ovarian Cancer, Endometrial Cancer, Ovarian Carcinosarcoma, Hysterectomy, and Salpingo-Oophorectomy.

Expertise in
17
conditions
Dr. Amir A. Jazaeri
Obstetrics and Gynecology | Gynecologic Oncology | Oncology
Expertise in
17
conditions
Dr. Amir A. Jazaeri
Obstetrics and Gynecology | Gynecologic Oncology | Oncology

MD Anderson

7900 Fannin St, Suite 2500, 
Houston, TX 
 (22.3 mi)
713-792-1380
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Amir Jazaeri is an Obstetrics and Gynecologist and a Gynecologic Oncologist in Houston, Texas. Dr. Jazaeri is highly rated in 17 conditions, according to our data. His top areas of expertise are Ovarian Cancer, Endometrial Cancer, Melanoma, Endoscopy, and Oophorectomy.

Expertise in
24
conditions
Dr. Michael A. Belfort
Neonatology | Obstetrics and Gynecology
Expertise in
24
conditions
Dr. Michael A. Belfort
Neonatology | Obstetrics and Gynecology
6651 Main St, Suite 420, 
Houston, TX 
 (22.9 mi)
832-828-3660
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Michael Belfort is a Neonatologist and an Obstetrics and Gynecologist in Houston, Texas. Dr. Belfort is highly rated in 24 conditions, according to our data. His top areas of expertise are Myelomeningocele, Twin-To-Twin Transfusion Syndrome, Polyhydramnios, Hysterectomy, and Endoscopy. Dr. Belfort is currently accepting new patients.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile